Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

被引:19
|
作者
David, O [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
Akt; PTEN; cell survival; immunohistochemistry; lung cancer;
D O I
10.1111/j.1582-4934.2001.tb00178.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt (1) and PTEN (2). Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
引用
收藏
页码:430 / 433
页数:4
相关论文
共 50 条
  • [21] Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma
    Jakobsen, Kristine R.
    Paulsen, Birgitte S.
    Baek, Rikke
    Varming, Kim
    Sorensen, Boe S.
    Jorgensen, Malene M.
    JOURNAL OF EXTRACELLULAR VESICLES, 2015, 4 : 1 - 10
  • [22] Prognostic markers for stage I non-small cell lung cancer - Reply
    Mizuguchi, Shinjiro
    Nishiyama, Noritoshi
    LUNG CANCER, 2008, 59 (02) : 274 - 275
  • [23] Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
    Peng B.
    Zhang J.
    Woods J.S.
    Peng W.
    Frontiers of Medicine in China, 2009, 3 (3): : 245 - 255
  • [24] Vicenin-2 acts as a radiosensitizer of the non-small cell lung cancer by lowering Akt expression
    Baruah, Taranga Jyoti
    Kma, Lakhon
    BIOFACTORS, 2019, 45 (02) : 200 - 210
  • [25] Pectolinarigenin inhibits non-small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway
    Xu, Fei
    Gao, Xuan
    Pan, Huiyun
    ONCOLOGY REPORTS, 2018, 40 (06) : 3458 - 3468
  • [26] Angiogenic markers in breath condensate identify non-small cell lung cancer
    Gessner, C.
    Rechner, B.
    Hammerschmidt, S.
    Kuhn, H.
    Hoheisel, G.
    Sack, U.
    Ruschpler, P.
    Wirtz, H.
    LUNG CANCER, 2010, 68 (02) : 177 - 184
  • [27] LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers
    Fu, Jiang
    Yu, Li
    Yan, Hang
    Tang, Shengjie
    Wang, Zixu
    Dai, Tingting
    Chen, Haoyu
    Zhang, Song
    Hu, Haiyang
    Liu, Tao
    Tang, Shoujun
    He, Rong
    Zhou, Haining
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [28] Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
    Paci, Massimiliano
    Maramotti, Sally
    Bellesia, Enrica
    Formisano, Debora
    Albertazzi, Laura
    Ricchetti, Tommaso
    Ferrari, Guglielmo
    Annessi, Valerio
    Lasagni, Daniela
    Carbonelli, Cristiano
    De Franco, Salvatore
    Brini, Maria
    Sgarbi, Giorgio
    Lodi, Renzo
    LUNG CANCER, 2009, 64 (01) : 92 - 97
  • [29] Diagnostic Value of Circulating CXC Chemokines in Non-small Cell Lung Cancer
    Spaks, Artjoms
    Jaunalksne, Inta
    Spaka, Irina
    Chudasama, Dimple
    Pirtnieks, Ainis
    Krievins, Dainis
    ANTICANCER RESEARCH, 2015, 35 (12) : 6979 - 6983
  • [30] Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer
    Nicos, Marcin
    Krawczyk, Pawel
    Jarosz, Bozena
    Sawicki, Marek
    Trojanowski, Tomasz
    Milanowski, Janusz
    BRAIN TUMOR PATHOLOGY, 2017, 34 (01) : 36 - 41